News
Eli Lilly lands an $870 million pact with Camurus to build long-acting obesity treatments, tapping FluidCrystalslow-release ...
It’s a pool Lilly King knows very well, one she’s been racing at since she was 10-years-old. So, it’s only fitting that her last swim meet on U.S. soil would be right here, at the IU Natatorium. “This ...
3h
Asianet Newsable on MSNMetsera Stock Climbs On Positive Results From Early Stage Trial For Investigational Weight-Loss Drug: Retail Chatter ExplodesThe company said that the drug, MET-233i, demonstrated up to 8.4% mean placebo-subtracted weight loss at day 36.
Dykstra served as vice president of religion at the Lilly Endowment in Indianapolis, where he was responsible for overseeing ...
National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would ...
From June 22-25, 160 leading minds will explore cutting-edge innovations and pressing issues shaping the future of health, medicine, and science. Speakers include NIH Director Jay Bhattacharya, ...
Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...
Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will ...
13h
Zacks Investment Research on MSNEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Village Health Workers in Zimbabwe use digital medical equipment and smartphones to diagnose and treat childhood ...
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results